Relevant bibliographies by topics / Proteins – Biotechnology / Journal articles

Journal articles on the topic 'Proteins – Biotechnology'

To see the other types of publications on this topic, follow the link: Proteins – Biotechnology.
Author: Grafiati
Published: 4 June 2021
Last updated: 19 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Proteins – Biotechnology.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Lilie, Hauke. "Designer proteins in biotechnology." EMBO reports 4, no. 4 (March 14, 2003): 346–51. http://dx.doi.org/10.1038/sj.embor.embor808.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Uhlén, Mathias, Göran Forsberg, Tomas Moks, Maris Hartmanis, and Björn Nilsson. "Fusion proteins in biotechnology." Current Opinion in Biotechnology 3, no. 4 (August 1992): 363–69. http://dx.doi.org/10.1016/0958-1669(92)90164-e.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hodgson, John. "Proteins, biotechnology and Society." Trends in Biotechnology 6, no. 5 (May 1988): 79–80. http://dx.doi.org/10.1016/0167-7799(88)90059-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Peake, Ian. "Biotechnology of Plasma Proteins, Haemostasis, Thrombosis and Iron Proteins." Blood Coagulation & Fibrinolysis 2, no. 6 (December 1991): 779. http://dx.doi.org/10.1097/00001721-199112000-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Strege, Mark A., and Avinash L. Lagu. "Capillary electrophoresis of biotechnology-derived proteins." Electrophoresis 18, no. 12-13 (1997): 2343–52. http://dx.doi.org/10.1002/elps.1150181225.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jenkins, Richard O. "Proteins: Biotechnology and biochemistry: Walsh, G." Biochemistry and Molecular Biology Education 30, no. 4 (July 2002): 271–72. http://dx.doi.org/10.1002/bmb.2002.494030049998.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Vizcaino-Caston, Isaac, Chris Wyre, and Tim W. Overton. "Fluorescent proteins in microbial biotechnology—new proteins and new applications." Biotechnology Letters 34, no. 2 (October 8, 2011): 175–86. http://dx.doi.org/10.1007/s10529-011-0767-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Tami, Joseph A. "The Science of Biotechnology." Journal of Pharmacy Practice 11, no. 1 (February 1998): 19–27. http://dx.doi.org/10.1177/089719009801100105.

Full text
Abstract:
The quest to understand how genetic information is passed from one generation to the next reached a major milestone in the 1950s with the discovery of the complementary double-helix structure of DNA by Watson and Crick and the demonstration by Kornberg that DNA was capable of self-replication. These breakthroughs provided the stimulus for a flurry of research that culminated in a basic understanding of the genetic code and a statement of the central dogma of molecular biology: DNA goes to RNA goes to protein. In expressing a gene, RNA is formed from the DNA template in a process called transcription. The process of RNA forming protein is known as translation. During translation, amino acids are linked to form protein. The primary structure of proteins is thus determined by the sequence of amino acids. Using x-ray crystallography and computer imaging, it has been possible to determine the three-dimensional structure of many proteins and to design small molecule peptides which can either mimic or block the function of the protein and thus be useful therapeutic agents.
APA, Harvard, Vancouver, ISO, and other styles
9

Davies, J. E. "Biotechnology 1985: From proteins to small molecules." Experientia 42, no. 1 (January 1986): 87–88. http://dx.doi.org/10.1007/bf01975911.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Šamaj, J. "Plant biotechnology employing signalling and cytoskeletal proteins." New Biotechnology 44 (October 2018): S16. http://dx.doi.org/10.1016/j.nbt.2018.05.1252.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Nilsson, Björn, Göran Forsberg, Tomas Moks, Maris Hartmanis, and Mathias Uhlén. "Fusion proteins in biotechnology and structural biology." Current Opinion in Structural Biology 2, no. 4 (August 1992): 569–75. http://dx.doi.org/10.1016/0959-440x(92)90087-n.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

NILSSON, B. "Fusion proteins in biotechnology and structural biology." Current Biology 2, no. 9 (September 1992): 476. http://dx.doi.org/10.1016/0960-9822(92)90663-u.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

AD, Suleimanova. "Microbial Biotechnology Based Modified Yeast." Open Access Journal of Microbiology & Biotechnology 5, no. 1 (2020): 1–2. http://dx.doi.org/10.23880/oajmb-16000155.

Full text
Abstract:
The production of heterologous proteins, lipids and chemicals based on modified yeast is a rapidly developing area of microbial biotechnology. Methods of metabolic engineering and new technologies for editing genomes are used to create a fundamentally new high-performance industrially significant yeast strains with new properties.
APA, Harvard, Vancouver, ISO, and other styles
14

Dũng, Nguyễn Tiến, Đỗ Thị Vân Anh, Nguyễn Thị Minh Phương, Bùi Thị Huyền, Phạm Đình Minh, Đỗ Hữu Chí, Nguyễn Thị Phương Liên, Phan Văn Chi, and Lê Thị Bích Thảo. "1Institute of Biotechnology, Vietnam Academy of Science and Technology." Vietnam Journal of Biotechnology 15, no. 2 (April 20, 2018): 259–65. http://dx.doi.org/10.15625/1811-4989/15/2/12342.

Full text
Abstract:
Wasp venoms are complex mixtures of various types of compounds, of which proteins and peptides are major components. Beside its toxicity, wasp venom is potential for treatment of diseases. Characterization of venom proteins and peptides is the first and most important step toward its applications in medicine. Vietnam possesses many valuable materials, of which venoms could be used in medicine. In the present work, we aim to identify proteins and peptides in the venom of Vespa velutina (V. velutina), a species of social wasp indigenous to Southeast Asia including Vietnam using proteomic techniques. The venom isolated from V. velutina by manual extraction was digested with trypsin via the FASP (Filter Aided Sample Preparation) method and analyzed with liquid chromatography tandem - mass spectrometry (LC-MS/MS). The following protein identification, protein validation, and peptide de novo sequencing were carried out using the Peaks software. In total, we detected 36 proteins from V. velutina venom and many of them had been reported as venom-specific proteins. According to Gene Ontology Annotation (GOA), V. velutina venom proteins were functionally classified into five categories: binding proteins (53%), catalytic proteins (33%), structural proteins (8%), antioxidants (4%), and proteins with other functions (2%). In addition, 81 peptides were detected in the venom of V. velutina by de novo sequencing, of which 34 peptides (42%) are potential venom peptides. We introduced for the first time the collection of proteins and peptides from V. velutina venom, providing the basis for its further application in medicine.
APA, Harvard, Vancouver, ISO, and other styles
15

Prausnitz, J. M. "Molecular thermodynamics for some applications in biotechnology." Pure and Applied Chemistry 75, no. 7 (January 1, 2003): 859–73. http://dx.doi.org/10.1351/pac200375070859.

Full text
Abstract:
As biotechnology sweeps the world, it is appropriate to remember that the great virtue of thermodynamics is its broad range of applicability. As a result, there is a growing literature describing how chemical thermodynamics can be used to inform processes for old and new biochemical products for industry and medicine.A particular application of molecular thermodynamics concerns separation of aqueous proteins by selective precipitation. For this purpose, we need phase diagrams; for constructing such diagrams, we need to understand not only the qualitative nature of phase equilibria of aqueous proteins, but also the quantitative intermolecular forces between proteins in solution. Some examples are given to show how aqueous protein-protein forces can be calculated or measured to yield a potential of mean force and how that potential is then used along with a statistical-thermodynamic model to establish liquid -liquid and liquid -crystal equilibria. Such equilibria are useful not only for separation processes, but also for understanding diseases like Alzheimer’s, eye cataracts, and sickle-cell anemia that appear to be caused by protein agglomeration.
APA, Harvard, Vancouver, ISO, and other styles
16

Beales, Paul A., Sanobar Khan, Stephen P. Muench, and Lars J. C. Jeuken. "Durable vesicles for reconstitution of membrane proteins in biotechnology." Biochemical Society Transactions 45, no. 1 (February 8, 2017): 15–26. http://dx.doi.org/10.1042/bst20160019.

Full text
Abstract:
The application of membrane proteins in biotechnology requires robust, durable reconstitution systems that enhance their stability and support their functionality in a range of working environments. Vesicular architectures are highly desirable to provide the compartmentalisation to utilise the functional transmembrane transport and signalling properties of membrane proteins. Proteoliposomes provide a native-like membrane environment to support membrane protein function, but can lack the required chemical and physical stability. Amphiphilic block copolymers can also self-assemble into polymersomes: tough vesicles with improved stability compared with liposomes. This review discusses the reconstitution of membrane proteins into polymersomes and the more recent development of hybrid vesicles, which blend the robust nature of block copolymers with the biofunctionality of lipids. These novel synthetic vesicles hold great promise for enabling membrane proteins within biotechnologies by supporting their enhanced in vitro performance and could also contribute to fundamental biochemical and biophysical research by improving the stability of membrane proteins that are challenging to work with.
APA, Harvard, Vancouver, ISO, and other styles
17

Panchal, R., M. Smart, D. Bowser, D. Williams, and S. Petrou. "Pore-Forming Proteins and their Application in Biotechnology." Current Pharmaceutical Biotechnology 3, no. 2 (June 1, 2002): 99–115. http://dx.doi.org/10.2174/1389201023378418.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Zlobin, Nikolai E., and Vasiliy V. Taranov. "Application of bacterial cold shock proteins in biotechnology." Bulletin of the Moscow State Regional University (Natural Sciences), no. 1 (2018): 86–94. http://dx.doi.org/10.18384/2310-7189-2018-1-86-94.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Ladics, Gregory. "Safety assessment of proteins utilized in agricultural biotechnology." Toxicology Letters 229 (September 2014): S25. http://dx.doi.org/10.1016/j.toxlet.2014.06.123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Service, R. F. "BIOTECHNOLOGY: Yeast Engineered to Produce Sugared Human Proteins." Science 301, no. 5637 (August 29, 2003): 1171. http://dx.doi.org/10.1126/science.301.5637.1171.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Lehrer, Samuel B., W. Elliott Horner, Gerald Reese, and Steven Taylor. "Why are some proteins allergenic? Implications for biotechnology." Critical Reviews in Food Science and Nutrition 36, no. 6 (July 1996): 553–64. http://dx.doi.org/10.1080/10408399609527739.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Lynch, Thomas J. "Biotechnology: alternatives to human plasma-derived therapeutic proteins." Best Practice & Research Clinical Haematology 13, no. 4 (December 2000): 669–88. http://dx.doi.org/10.1053/beha.2000.0100.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Aebersold, Ruedi. "Mass spectrometry of proteins and peptides in biotechnology." Current Opinion in Biotechnology 4, no. 4 (August 1993): 412–19. http://dx.doi.org/10.1016/0958-1669(93)90006-i.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Mrsa, Vladimir, Antonija Grbavac, Igor Stuparevic, and Renata Teparic. "Application of surface display of proteins in biotechnology." Journal of Biotechnology 256 (August 2017): S12—S13. http://dx.doi.org/10.1016/j.jbiotec.2017.06.044.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Yakimov, A. P., A. S. Afanaseva, M. A. Khodorkovskiy, and M. G. Petukhov. "Design of Stable α-Helical Peptides and Thermostable Proteins in Biotechnology and Biomedicine." Acta Naturae 8, no. 4 (December 15, 2016): 70–81. http://dx.doi.org/10.32607/20758251-2016-8-4-70-81.

Full text
Abstract:
-Heliсes are the most frequently occurring elements of the secondary structure in water-soluble globular proteins. Their increased conformational stability is among the main reasons for the high thermal stability of proteins in thermophilic bacteria. In addition, -helices are often involved in protein interactions with other proteins, nucleic acids, and the lipids of cell membranes. That is why the highly stable -helical peptides used as highly active and specific inhibitors of protein-protein and other interactions have recently found more applications in medicine. Several different approaches have been developed in recent years to improve the conformational stability of -helical peptides and thermostable proteins, which will be discussed in this review. We also discuss the methods for improving the permeability of peptides and proteins across cellular membranes and their resistance to intracellular protease activity. Special attention is given to the SEQOPT method (http://mml.spbstu.ru/services/seqopt/), which is used to design conformationally stable short -helices.
APA, Harvard, Vancouver, ISO, and other styles
26

Niemeyer, Christof M. "Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science." Angewandte Chemie International Edition 40, no. 22 (November 16, 2001): 4128–58. http://dx.doi.org/10.1002/1521-3773(20011119)40:22<4128::aid-anie4128>3.0.co;2-s.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Graf, Alexandra, Martin Dragosits, Brigitte Gasser, and Diethard Mattanovich. "Yeast systems biotechnology for the production of heterologous proteins." FEMS Yeast Research 9, no. 3 (May 2009): 335–48. http://dx.doi.org/10.1111/j.1567-1364.2009.00507.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Peumans, Willy J., and Els J. M. Van Damme. "Plant Lectins: Versatile Proteins with Important Perspectives in Biotechnology." Biotechnology and Genetic Engineering Reviews 15, no. 1 (April 1998): 199–228. http://dx.doi.org/10.1080/02648725.1998.10647956.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Kennedy, John F., and Yu-Tien Lin. "Industrial Proteins in Perspective—Progress in Biotechnology Vol. 23." Carbohydrate Polymers 55, no. 1 (January 2004): 118. http://dx.doi.org/10.1016/j.carbpol.2003.08.013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Kumar, Awanish, Kavya Bhakuni, and Pannuru Venkatesu. "Strategic planning of proteins in ionic liquids: future solvents for the enhanced stability of proteins against multiple stresses." Physical Chemistry Chemical Physics 21, no. 42 (2019): 23269–82. http://dx.doi.org/10.1039/c9cp04772g.

Full text
Abstract:
Ionic liquids (ILs) represent as solvents or co-solvents for protein stabilization and refolding. Thus, ILs are replacement to toxic organic solvents in chemical, biotechnology and biomedical applications.
APA, Harvard, Vancouver, ISO, and other styles
31

Ningrum, Dian Eka A. F., Mohamad Amin, and Betty Lukiati. "Bioinformatics Approach Based Research of Profile Protein Carbonic Anhydrase II Analysis as a Potential Candidate Cause Autism for The Variation of Learning Subjects Biotechnology." Jurnal Pendidikan Biologi Indonesia 3, no. 1 (March 31, 2017): 28. http://dx.doi.org/10.22219/jpbi.v3i1.3799.

Full text
Abstract:
This study aims to determine the needs of learning variations on Biotechnology courses using bioinformatics approaches. One example of applied use of bioinformatics in biotechnology course is the analysis of protein profiles carbonic anhydrase II as a potential cause of autism candidate. This research is a qualitative descriptive study consisted of two phases. The first phase of the data obtained from observations of learning, student questionnaires, and questionnaires lecturer. Results from the first phase, namely the need for variations learning in Biotechnology course using bioinformatics. Collecting data on the second stage uses three webserver to predict the target protein and scientific articles. Visualization of proteins using PyMOL software. 3 based webserver which is used, the candidate of target proteins associated with autism is carbonic anhydrase II. The survey results revealed that the protein carbonic anhydrase II as a potential candidate for the cause of autism classified metaloenzim are able to bind with heavy metals. The content of heavy metals in autistic patients high that affect metabolism. This prediction of protein candidate cause autism is applied use to solve the problem in society, so that can achieve the learning outcome in biotechnology course.
APA, Harvard, Vancouver, ISO, and other styles
32

Mitchell, Daniel E., Alice E. R. Fayter, Robert C. Deller, Muhammad Hasan, Jose Gutierrez-Marcos, and Matthew I. Gibson. "Ice-recrystallization inhibiting polymers protect proteins against freeze-stress and enable glycerol-free cryostorage." Materials Horizons 6, no. 2 (2019): 364–68. http://dx.doi.org/10.1039/c8mh00727f.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Haque, R. U., F. Paradisi, and T. Allers. "Haloferax volcanii for biotechnology applications: challenges, current state and perspectives." Applied Microbiology and Biotechnology 104, no. 4 (December 20, 2019): 1371–82. http://dx.doi.org/10.1007/s00253-019-10314-2.

Full text
Abstract:
AbstractHaloferax volcanii is an obligate halophilic archaeon with its origin in the Dead Sea. Simple laboratory culture conditions and a wide range of genetic tools have made it a model organism for studying haloarchaeal cell biology. Halophilic enzymes of potential interest to biotechnology have opened up the application of this organism in biocatalysis, bioremediation, nanobiotechnology, bioplastics and the biofuel industry. Functionally active halophilic proteins can be easily expressed in a halophilic environment, and an extensive genetic toolkit with options for regulated protein overexpression has allowed the purification of biotechnologically important enzymes from different halophiles in H. volcanii. However, corrosion mediated damage caused to stainless-steel bioreactors by high salt concentrations and a tendency to form biofilms when cultured in high volume are some of the challenges of applying H. volcanii in biotechnology. The ability to employ expressed active proteins in immobilized cells within a porous biocompatible matrix offers new avenues for exploiting H. volcanii in biotechnology. This review critically evaluates the various application potentials, challenges and toolkits available for using this extreme halophilic organism in biotechnology.
APA, Harvard, Vancouver, ISO, and other styles
34

Geisow, Michael J. "Characterizing Recombinant Proteins." Bio/Technology 9, no. 10 (October 1991): 921–24. http://dx.doi.org/10.1038/nbt1091-921.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Nchinda, Godwin W., Nadia Al-Atoom, Mamie T. Coats, Jacqueline M. Cameron, and Alain B. Waffo. "Uniqueness of RNA Coliphage Qβ Display System in Directed Evolutionary Biotechnology." Viruses 13, no. 4 (March 27, 2021): 568. http://dx.doi.org/10.3390/v13040568.

Full text
Abstract:
Phage display technology involves the surface genetic engineering of phages to expose desirable proteins or peptides whose gene sequences are packaged within phage genomes, thereby rendering direct linkage between genotype with phenotype feasible. This has resulted in phage display systems becoming invaluable components of directed evolutionary biotechnology. The M13 is a DNA phage display system which dominates this technology and usually involves selected proteins or peptides being displayed through surface engineering of its minor coat proteins. The displayed protein or peptide’s functionality is often highly reduced due to harsh treatment of M13 variants. Recently, we developed a novel phage display system using the coliphage Qβ as a nano-biotechnology platform. The coliphage Qβ is an RNA phage belonging to the family of Leviviridae, a long investigated virus. Qβ phages exist as a quasispecies and possess features making them comparatively more suitable and unique for directed evolutionary biotechnology. As a quasispecies, Qβ benefits from the promiscuity of its RNA dependent RNA polymerase replicase, which lacks proofreading activity, and thereby permits rapid variant generation, mutation, and adaptation. The minor coat protein of Qβ is the readthrough protein, A1. It shares the same initiation codon with the major coat protein and is produced each time the ribosome translates the UGA stop codon of the major coat protein with the of misincorporation of tryptophan. This misincorporation occurs at a low level (1/15). Per convention and definition, A1 is the target for display technology, as this minor coat protein does not play a role in initiating the life cycle of Qβ phage like the pIII of M13. The maturation protein A2 of Qβ initiates the life cycle by binding to the pilus of the F+ host bacteria. The extension of the A1 protein with a foreign peptide probe recognizes and binds to the target freely, while the A2 initiates the infection. This avoids any disturbance of the complex and the necessity for acidic elution and neutralization prior to infection. The combined use of both the A1 and A2 proteins of Qβ in this display system allows for novel bio-panning, in vitro maturation, and evolution. Additionally, methods for large library size construction have been improved with our directed evolutionary phage display system. This novel phage display technology allows 12 copies of a specific desired peptide to be displayed on the exterior surface of Qβ in uniform distribution at the corners of the phage icosahedron. Through the recently optimized subtractive bio-panning strategy, fusion probes containing up to 80 amino acids altogether with linkers, can be displayed for target selection. Thus, combined uniqueness of its genome, structure, and proteins make the Qβ phage a desirable suitable innovation applicable in affinity maturation and directed evolutionary biotechnology. The evolutionary adaptability of the Qβ phage display strategy is still in its infancy. However, it has the potential to evolve functional domains of the desirable proteins, glycoproteins, and lipoproteins, rendering them superior to their natural counterparts.
APA, Harvard, Vancouver, ISO, and other styles
36

Tami, Joseph A. "Major Techniques of Biotechnology." Journal of Pharmacy Practice 11, no. 1 (February 1998): 28–37. http://dx.doi.org/10.1177/089719009801100106.

Full text
Abstract:
Since the discovery of the structure and function of DNA over 40 years ago, the established knowledge of molecular biology has increased dramatically, and many new tools have been discovered and utilized by scientists to develop new therapeutic agents. Important tools that are used in recombinant DNA technology include restriction endonucleases (cleave DNA), DNA ligase (link DNA molecules together), and cloning vectors (place foreign DNA into an organism such as bacterial or yeast cells in order to mass produce the protein encoded by that foreign DNA). The development of hybridoma technology provided a method to produce virtually unlimited quantities of pure antibody with a single specificity. These immuno-globulins are known as monoclonal antibodies, and have provided both therapeutic and diagnostic agents. Antisense molecules are oligonucleotides which bind to the messenger RNA (mRNA) of a target gene and selectively inhibit the production of specific proteins. Potential applications for these molecules include cancer and viral and inflammatory diseases. The more recent development of the polymerase chain reaction (PCR) has provided a tool that has revolutionized diagnostic testing in diverse areas such as infectious diseases, genetic abnormalities, and cancer.
APA, Harvard, Vancouver, ISO, and other styles
37

Gonzalez-Vazquez, Maria Cristina, Ruth Abril Vela-Sanchez, Norma Elena Rojas-Ruiz, and Alejandro Carabarin-Lima. "Importance of Cry Proteins in Biotechnology: Initially a Bioinsecticide, Now a Vaccine Adjuvant." Life 11, no. 10 (September 23, 2021): 999. http://dx.doi.org/10.3390/life11100999.

Full text
Abstract:
A hallmark of Bacillus thuringiensis bacteria is the formation of one or more parasporal crystal (Cry) proteins during sporulation. The toxicity of these proteins is highly specific to insect larvae, exerting lethal effects in different insect species but not in humans or other mammals. The aim of this review is to summarize previous findings on Bacillus thuringiensis, including the characteristics of the bacterium, its subsequent contribution to biotechnology as a bioinsecticide due to the presence of Cry proteins, and its potential application as an adjuvant. In several studies, Cry proteins have been administered together with specific antigens to immunize experimental animal models. The results have shown that these proteins can enhance immunogenicity by generating an adequate immune response capable of protecting the model against an experimental infectious challenge, whereas protection is decreased when the specific antigen is administered without the Cry protein. Therefore, based on previous results and the structural homology between Cry proteins, these molecules have arisen as potential adjuvants in the development of vaccines for both animals and humans. Finally, a model of the interaction of Cry proteins with different components of the immune response is proposed.
APA, Harvard, Vancouver, ISO, and other styles
38

Han, Mee-Jung, Hongseok Yun, and Sang Yup Lee. "Microbial small heat shock proteins and their use in biotechnology." Biotechnology Advances 26, no. 6 (November 2008): 591–609. http://dx.doi.org/10.1016/j.biotechadv.2008.08.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Kriz, Alan L., and Brian A. Larkins. "Biotechnology of Seed Crops: Genetic Engineering of Seed Storage Proteins." HortScience 26, no. 8 (August 1991): 1036–41. http://dx.doi.org/10.21273/hortsci.26.8.1036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Amtul, Zareen, and Amal A. Aziz. "Microbial Proteins as Novel Industrial Biotechnology Hosts to Treat Epilepsy." Molecular Neurobiology 54, no. 10 (December 1, 2016): 8211–24. http://dx.doi.org/10.1007/s12035-016-0279-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

King, David J. "High-performance liquid chromatography of proteins and peptides in biotechnology." TrAC Trends in Analytical Chemistry 6, no. 5 (May 1987): X—XI. http://dx.doi.org/10.1016/0165-9936(87)87050-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Fleurence, Joël. "Seaweed proteins." Trends in Food Science & Technology 10, no. 1 (January 1999): 25–28. http://dx.doi.org/10.1016/s0924-2244(99)00015-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Park, Jae W. "Seafood proteins." Trends in Food Science & Technology 5, no. 12 (December 1994): 408. http://dx.doi.org/10.1016/0924-2244(94)90176-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Selitrennikoff, Claude P. "Antifungal Proteins." Applied and Environmental Microbiology 67, no. 7 (July 1, 2001): 2883–94. http://dx.doi.org/10.1128/aem.67.7.2883-2894.2001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

GIEGE, R. "Crystallogenesis of proteins." Trends in Biotechnology 7, no. 10 (October 1989): 277–82. http://dx.doi.org/10.1016/0167-7799(89)90047-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Bush, Peggy. "Pharmacotherapeutics of Biotechnology-Derived Products." Journal of Pharmacy Practice 11, no. 1 (February 1998): 54–71. http://dx.doi.org/10.1177/089719009801100109.

Full text
Abstract:
Biotechnology has contributed to important advances in the healthcare field. Products include various hormones, enzymes, cytokines, vaccines, and monoclonal antibodies, with use in diverse therapeutic areas. The majority of approved biotechnology-derived therapeutic products are recombinant proteins. Many have orphan drug status and, therefore, are used in relatively small patient populations. Newer generation biotechnology products are likely to include small molecules, gene therapy products, and increased numbers of vaccines and monoclonal antibody products. Biotechnology provides the means to develop diverse, innovative, and effective approaches to the prevention, treatment, and cure of human disease.
APA, Harvard, Vancouver, ISO, and other styles
47

Morley, Alec. "Biotechnology: Proteins to PCR—a course in strategies and lab techniques." Pathology 29, no. 4 (1997): 453. http://dx.doi.org/10.1016/s0031-3025(16)35008-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Nixon, Andrew E., and Steven M. Firestine. "Rational and “Irrational” Design of Proteins and Their Use in Biotechnology." IUBMB: Life 49, no. 3 (March 1, 2000): 181–87. http://dx.doi.org/10.1080/152165400306188.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Nixon, Andrew, and Steven Firestine. "Rational and ?Irrational? Design of Proteins and Their Use in Biotechnology." IUBMB Life 49, no. 3 (March 1, 2000): 181–87. http://dx.doi.org/10.1080/713803615.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Strege, Mark A., and Avinash L. Lagu. "Capillary electrophoretic separations of biotechnology-derived proteins inE. coli fermentation broth." Electrophoresis 16, no. 1 (1995): 642–46. http://dx.doi.org/10.1002/elps.11501601103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Proteins – Biotechnology' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography